Russia's Sputnik V vaccine to arrive in Kanpur medical college next week for Phase 2, 3 trials

▴ Russia's Sputnik V vaccine to arrive in Kanpur medical college next week for Phase 2, 3 trials
Dr Reddy's will conduct the clinical trials and, subject to approval, distribute the finished vaccine in India

Russia’s Sputnik V vaccine for coronavirus is likely to reach Kanpur’s Ganesh Shankar Vidyarthi Medical College by next week wherein the vaccine’s Phase 2 and Phase 3 human clinical trials will be conducted.

The Drug Control General of India had granted approval to the Russian Direct Investment Fund (RDIF) and Dr. Reddy's Laboratories Ltd to conduct late-stage clinical trials of the Russian Covid-19 vaccine, Sputnik V, in India, the sovereign wealth fund said on Saturday.

The DGCI had earlier put a stop on Dr Reddy's Laboratories conducting clinical trials for the Russian coronavirus vaccine Sputnik V. According to Reuters, the drug regulator had said the scale of Phase I and II trials conducted in Russia earlier this year was too small, requesting that they be repeated.

On October 13, the Hyderabad-based pharmaceutical firm had reapplied to the Indian drug regulator seeking permission to conduct combined phase 2 and 3 human clinical trials of the vaccine in the country, according to news agency PTI.

Now, following a new agreement, India will carry out an adaptive phase II and III human clinical trial involving 1,500 participants, RDIF was quoted by Reuters as saying.

Under the deal, Dr. Reddy's will conduct the clinical trials and, subject to approval, distribute the finished vaccine in India. RDIF will supply 100 million doses to Dr. Reddy's.

Sputnik V, a vaccine against the novel coronavirus, has been developed by the Gamaleya National Research Center of Epidemiology and Microbiology and the RDIF.

With inputs from PTI and Reuters

Story Source > https://www.indiatoday.in/coronavirus-outbreak/story/russia-s-sputnik-v-vaccine-to-arrive-in-kanpur-medical-college-for-phase-2-3-trials-1741150-2020-11-15

Tags : #DrReddysLab #GaneshShankarVidyarthiMedicalCollegeKanpur #LatestNewsonCOVIDVaccine16thNov #DCGI #RDIF #HumanClinicalTrial

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026